- Home
- DNTH vs WASH Comparison
DNTH vs WASH Comparison
Compare DNTH & WASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- WASH
- Stock Information
- Founded
- DNTH 2015
- WASH 1800
- Country
- DNTH United States
- WASH United States
- Employees
- DNTH N/A
- WASH N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- WASH Major Banks
- Sector
- DNTH Health Care
- WASH Finance
- Exchange
- DNTH Nasdaq
- WASH Nasdaq
- Market Cap
- DNTH 724.8M
- WASH 647.4M
- IPO Year
- DNTH N/A
- WASH N/A
- Fundamental
- Price
- DNTH $23.67
- WASH $31.50
- Analyst Decision
- DNTH Strong Buy
- WASH Hold
- Analyst Count
- DNTH 9
- WASH 1
- Target Price
- DNTH $46.43
- WASH $34.00
- AVG Volume (30 Days)
- DNTH 198.9K
- WASH 189.5K
- Earning Date
- DNTH 03-20-2025
- WASH 01-29-2025
- Dividend Yield
- DNTH N/A
- WASH 7.11%
- EPS Growth
- DNTH N/A
- WASH N/A
- EPS
- DNTH N/A
- WASH N/A
- Revenue
- DNTH $5,366,000.00
- WASH $98,251,000.00
- Revenue This Year
- DNTH $100.14
- WASH N/A
- Revenue Next Year
- DNTH N/A
- WASH $9.92
- P/E Ratio
- DNTH N/A
- WASH N/A
- Revenue Growth
- DNTH 51.41
- WASH N/A
- 52 Week Low
- DNTH $18.35
- WASH $24.11
- 52 Week High
- DNTH $33.77
- WASH $40.59
- Technical
- Relative Strength Index (RSI)
- DNTH 53.31
- WASH 40.45
- Support Level
- DNTH $22.77
- WASH $32.14
- Resistance Level
- DNTH $25.46
- WASH $33.16
- Average True Range (ATR)
- DNTH 1.49
- WASH 0.89
- MACD
- DNTH 0.13
- WASH -0.12
- Stochastic Oscillator
- DNTH 57.18
- WASH 2.95
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.